Switzerland· 47688035
Metaneuron N, Tropfen zum Einnehmen
A medicinal product containing argentum nitricum (hab) d5, mandragora (ph.eur.hom.) d6 (ph.eur.hom. 1.1.8), petasites hybridus (hab) d6, piper methysticum e radice siccata d6 (hab 4a), ferula moschata e radice siccata d2 (hab 4a), registered in Switzerland by metapharmaka GmbH and dispensed under Swissmedic category D.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
The record
At a glance
Swissmedic (Switzerland)- Active substance
- argentum nitricum (HAB) D5, mandragora (Ph.Eur.Hom.) D6 (Ph.Eur.Hom. 1.1.8), petasites hybridus (HAB) D6, piper methysticum e radice siccata D6 (HAB 4a), ferula moschata e radice siccata D2 (HAB 4a)
- Manufacturer
- metapharmaka GmbH
- Country
- Switzerland (CH)
- ATC code
- —
- Swissmedic category
- D
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e02a0d8c-c558-4e3a-919f-a676c9930d81 GET /v1/drugs/e02a0d8c-c558-4e3a-919f-a676c9930d81?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{}See everything about argentum nitricum (hab) d5, mandragora (ph.eur.hom.) d6 (ph.eur.hom. 1.1.8), petasites hybridus (hab) d6, piper methysticum e radice siccata d6 (hab 4a), ferula moschata e radice siccata d2 (hab 4a).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.